On. Target Molecules Biotech Inc. (O.TM Biotech) is an innovative Research and Development Company which was established in 2013 to bring to life a vision of developing a new approach to treating cancer which would alleviate patient suffering. O.TM Biotech is developing a novel anticancer biologic drug which works against several cancers. Our Company has successfully designed, developed and synthesized an anticancer molecule which causes natural cell death in several cancer cell lines in-vitro. We envision our Company creating breakthrough technologies in the diagnosis and treatment of cancer. O.TM Biotech’s strength is in its acquired Intellectual Property, a seasoned team, a clear and focused plan to getting the product to the patient and addressing areas of high need. O.TM Biotech has made remarkable progress over the past years. The Company is positioning itself for growth, diversification, licensing and potential joint ventures in multiple ways in the next 4-5 years. Building on its success to date, O.TM Biotech is poised to take on the remaining phases in its fight against cancer at scale and speed. O.TM Biotech is firmly committed to bringing its path-breaking treatment of cancer to patients.